Related Experiment Video

Updated: Aug 5, 2026

On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

Increased inflammatory markers in children with familial hypercholesterolaemia

T Ueland1, M N Vissers, A Wiegman

  • 1Research Institute for Internal Medicine, Section of Endocrinology, Rikshospitalet, University of Oslo, Norway. thor.ueland@medisin.uio.no

European Journal of Clinical Investigation
|March 2, 2006
PubMed

Insights

Children with familial hypercholesterolaemia (FH) show higher inflammation markers like neopterin and hsCRP. Statins had minimal impact on these markers in FH children, unlike in adults.

Area of Science:

  • Pediatric Cardiology
  • Inflammation Research
  • Genetic Lipid Disorders

Background:

  • Limited data on inflammatory markers in pediatric hypercholesterolemia.
  • Investigating inflammation in children with heterozygous familial hypercholesterolaemia (FH).
  • Assessing neopterin, hsCRP, and sCD40L levels in FH children.

Purpose of the Study:

  • To determine the extent and nature of inflammation in children with FH.
  • To compare inflammatory markers in FH children versus their unaffected siblings.
  • To evaluate the impact of pravastatin treatment on these markers.

Main Methods:

  • Compared inflammatory marker concentrations in 207 FH children and 84 healthy siblings.
  • Measured serum neopterin, hsCRP, and sCD40L.
  • Assessed the effect of 2-year pravastatin or placebo treatment.

Main Results:

  • FH children had significantly higher neopterin and hsCRP levels than siblings.
  • sCD40L levels did not differ between groups.
  • Pravastatin reduced neopterin but not other markers, with no significant difference from placebo.

Conclusions:

  • Findings suggest low-grade monocyte/macrophage activation in early atherogenesis in FH children.
  • Inflammation and statin's anti-inflammatory effects appear less pronounced in FH children than adults.
  • Highlights differences in inflammatory profiles between pediatric and adult FH.
Abstract

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...